These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 32393819)

  • 1. COVID-19 outcomes and the human genome.
    Murray MF; Kenny EE; Ritchie MD; Rader DJ; Bale AE; Giovanni MA; Abul-Husn NS
    Genet Med; 2020 Jul; 22(7):1175-1177. PubMed ID: 32393819
    [No Abstract]   [Full Text] [Related]  

  • 2. The COVID-19 Host Genetics Initiative, a global initiative to elucidate the role of host genetic factors in susceptibility and severity of the SARS-CoV-2 virus pandemic.
    COVID-19 Host Genetics Initiative
    Eur J Hum Genet; 2020 Jun; 28(6):715-718. PubMed ID: 32404885
    [No Abstract]   [Full Text] [Related]  

  • 3. Societal considerations in host genome testing for COVID-19.
    Milne R
    Genet Med; 2020 Sep; 22(9):1464-1466. PubMed ID: 32514089
    [No Abstract]   [Full Text] [Related]  

  • 4. Global Initiative Seeks to Crack the COVID-19 Genetic Code.
    Am J Med Genet A; 2020 Sep; 182(9):1998-1999. PubMed ID: 32881367
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of host genetics in the immune response to SARS-CoV-2 and COVID-19 susceptibility and severity.
    Ovsyannikova IG; Haralambieva IH; Crooke SN; Poland GA; Kennedy RB
    Immunol Rev; 2020 Jul; 296(1):205-219. PubMed ID: 32658335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Genetic and epigenetic variability, and the Covid-19 pandemic].
    Rivera-Silva G
    Salud Publica Mex; 2020; 62(5):462-463. PubMed ID: 32668509
    [No Abstract]   [Full Text] [Related]  

  • 7. A singular view of COVID-19.
    Eisenstein M
    Nat Biotechnol; 2020 Sep; 38(9):1016-1020. PubMed ID: 32782414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sampling the host response to SARS-CoV-2 in hospitals under siege.
    Charney AW; Simons NW; Mouskas K; Lepow L; Cheng E; Le Berichel J; Chang C; Marvin R; Del Valle DM; Calorossi S; Lansky A; Walker L; Patel M; Xie H; Yi N; Yu A; Kang G; Mendoza A; Liharska LE; Moya E; Hartnett M; Hatem S; Wilkins L; Eaton M; Jamal H; Tuballes K; Chen ST; Tabachnikova A; Chung J; Harris J; Batchelor C; Lacunza J; Yishak M; Argueta K; Karekar N; Lee B; Kelly G; Geanon D; Handler D; Leech J; Stefanos H; Dawson T; Scott I; Francoeur N; Johnson JS; Vaid A; Glicksberg BS; Nadkarni GN; Schadt EE; Gelb BD; Rahman A; Sebra R; Martin G; ; Marron T; Beckmann N; Kim-Schulze S; Gnjatic S; Merad M
    Nat Med; 2020 Aug; 26(8):1157-1158. PubMed ID: 32719485
    [No Abstract]   [Full Text] [Related]  

  • 9. CCR5 Δ32 minorallele is associated with susceptibility to SARS-CoV-2 infection and death: An epidemiological investigation.
    Panda AK; Padhi A; Prusty BAK
    Clin Chim Acta; 2020 Nov; 510():60-61. PubMed ID: 32653483
    [No Abstract]   [Full Text] [Related]  

  • 10. COVID-19 puts health research to the test in Africa.
    Adepoju P
    Nat Med; 2020 Sep; 26(9):1312-1314. PubMed ID: 32839621
    [No Abstract]   [Full Text] [Related]  

  • 11. Functional prediction and comparative population analysis of variants in genes for proteases and innate immunity related to SARS-CoV-2 infection.
    Klaassen K; Stankovic B; Zukic B; Kotur N; Gasic V; Pavlovic S; Stojiljkovic M
    Infect Genet Evol; 2020 Oct; 84():104498. PubMed ID: 32771700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal profiling of plasma cytokines, chemokines and growth factors from mild, severe and fatal COVID-19 patients.
    Xu ZS; Shu T; Kang L; Wu D; Zhou X; Liao BW; Sun XL; Zhou X; Wang YY
    Signal Transduct Target Ther; 2020 Jun; 5(1):100. PubMed ID: 32561706
    [No Abstract]   [Full Text] [Related]  

  • 13. An evidence for correlation between the glutathione S-transferase T1 (GSTT1) polymorphism and outcome of COVID-19.
    Saadat M
    Clin Chim Acta; 2020 Sep; 508():213-216. PubMed ID: 32454047
    [No Abstract]   [Full Text] [Related]  

  • 14. Host genetic factors and susceptibility to SARS-CoV-2 infection.
    Schurr TG
    Am J Hum Biol; 2020 Sep; 32(5):e23497. PubMed ID: 32876373
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardiometabolic Traits, Sepsis, and Severe COVID-19: A Mendelian Randomization Investigation.
    Ponsford MJ; Gkatzionis A; Walker VM; Grant AJ; Wootton RE; Moore LSP; Fatumo S; Mason AM; Zuber V; Willer C; Rasheed H; Brumpton B; Hveem K; Kristian Damås J; Davies N; Åsvold BO; Solligård E; Jones S; Burgess S; Rogne T; Gill D
    Circulation; 2020 Nov; 142(18):1791-1793. PubMed ID: 32966752
    [No Abstract]   [Full Text] [Related]  

  • 16. Identification of SARS-CoV-2 clusters from symptomatic cases in India.
    Jain P; Prakash O; Nyayanit DA; Verma AK; Yadav PD; Khan DN; Prakash S; Mishra H; Reddy H; Agarwal A; Bhatt MB; Jain A
    Indian J Med Res; 2020 Jul & Aug; 152(1 & 2):111-115. PubMed ID: 32859867
    [No Abstract]   [Full Text] [Related]  

  • 17. A Global Effort to Define the Human Genetics of Protective Immunity to SARS-CoV-2 Infection.
    Casanova JL; Su HC;
    Cell; 2020 Jun; 181(6):1194-1199. PubMed ID: 32405102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic predisposition models to COVID-19 infection.
    Darbeheshti F; Rezaei N
    Med Hypotheses; 2020 Sep; 142():109818. PubMed ID: 32416414
    [No Abstract]   [Full Text] [Related]  

  • 19. Quasispecies analysis of the SARS-CoV-2 from representative clinical samples: A preliminary analysis.
    Nyayanit DA; Yadav PD; Kharde R; Shete-Aich A
    Indian J Med Res; 2020 Jul & Aug; 152(1 & 2):105-107. PubMed ID: 32773417
    [No Abstract]   [Full Text] [Related]  

  • 20. Genomic Epidemiology and its importance in the study of the COVID-19 pandemic.
    Rodriguez-Morales AJ; Balbin-Ramon GJ; Rabaan AA; Sah R; Dhama K; Paniz-Mondolfi A; Pagliano P; Esposito S
    Infez Med; 2020 Ahead of print Jun 1; 28(2):139-142. PubMed ID: 32275255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.